Orthocrat appoints new CFO from Teva
Orthocrat, a provider of orthopedic pre-operative digital templating software, has appointed Shaul Dabby as chief financial officer (CFO).
Dabby has joins Orthocrat from Teva Pharmaceutical Industries, where he served until recently as CFO of its international group, according to the Tel Aviv, Israel-based Orthocrat. In his position with Teva, Dabby was responsible for financial activities in all areas outside North America, Western Europe and Israel. He also played a role in integrating two Teva acquisitions, as well as several smaller purchases, the company said.
“We are very pleased to bring Shaul on board to further strengthen our management team,” said Zeev Glozman, Orthocrat's CEO.
Dabby has joins Orthocrat from Teva Pharmaceutical Industries, where he served until recently as CFO of its international group, according to the Tel Aviv, Israel-based Orthocrat. In his position with Teva, Dabby was responsible for financial activities in all areas outside North America, Western Europe and Israel. He also played a role in integrating two Teva acquisitions, as well as several smaller purchases, the company said.
“We are very pleased to bring Shaul on board to further strengthen our management team,” said Zeev Glozman, Orthocrat's CEO.